![]() |
GRK2 Inhibitor
- 品牌:MedKoo
- 產(chǎn)地:美國
- 貨號:563192
- cas:24269-96-3
- 發(fā)布日期: 2022-07-20
- 更新日期: 2024-08-12
產(chǎn)品詳請
產(chǎn)地 | 美國 |
品牌 | MedKoo |
貨號 | 563192 |
用途 | This product is for research use only, not for human or veterinary use. |
包裝規(guī)格 | 5.0mg; 10.0mg; 25.0mg; |
CAS編號 | 24269-96-3 |
純度 | >98%% |
是否進(jìn)口 | 是 |
中文名稱:呋喃妥因-13C3
中文別名:βARK1 Inhibitor
CAS No:24269-96-3
分子式:C12H9NO6
沸點(diǎn):408.4±45.0 °C(Predicted)
密度:1.400±0.06 g/cm3(Predicted)
用途:5-[2-(5-Nitro-2-furanyl)ethenyl]-2-furancarboxylic Acid Methyl Ester is an inhibitor of G protein-coupled receptor kinase 2. 5-[2-(5-Nitro-2-furanyl)ethenyl]-2-furancarboxylic Acid Methyl Ester was shown to normalize vascular endothelial function in type 2 diabetic mice by improving β-arrestin 2 tr..
中文別名:βARK1 Inhibitor
CAS No:24269-96-3
分子式:C12H9NO6
沸點(diǎn):408.4±45.0 °C(Predicted)
密度:1.400±0.06 g/cm3(Predicted)
用途:5-[2-(5-Nitro-2-furanyl)ethenyl]-2-furancarboxylic Acid Methyl Ester is an inhibitor of G protein-coupled receptor kinase 2. 5-[2-(5-Nitro-2-furanyl)ethenyl]-2-furancarboxylic Acid Methyl Ester was shown to normalize vascular endothelial function in type 2 diabetic mice by improving β-arrestin 2 tr..
相關(guān)產(chǎn)品: